Skip to main content
. 2012 Nov 30;7(11):e50816. doi: 10.1371/journal.pone.0050816

Table 1. Validation of each method used in the virtual screening workflow.

Set of Compounds Number of Compounds Structure-based pharmacophore screening Electrostatic/shape similarity analysis Global virtual screening
anti pharmacophore partial agonist pharmacophore
in vacuo conformations in vacuo conformations docking poses
Partial Agonists 19 12 10 8 5 5
Full Agonists 135 31 11 7 1 1
Decoys 3122 2204 964 382 16 16
Enrichment Factor (EF) 2.45 1.90 1.98 11.28 39.19
EFmax 24.27 187.25 98.50 49.63 172.42
Sensitivity (Se) 77.04% 83.33% 80.00% 62.50% 26.32%
Specificity (Sp) 29.45% 56.38% 60.10% 95.63% 99.49%

A dataset of 19 known PPARγ partial agonists, 135 known PPARγ full agonists and 3122 decoys extracted from the DUD database were used. The values represent the number of compounds from each set that survived each step when applied sequentially.